Approvals/CIMA-AEMPS/LEVOSIMENDAN EQL PHARMA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

LEVOSIMENDAN EQL PHARMA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Eql Pharma Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e664c51a80e0b887
Drug Cima Aemps Name: LEVOSIMENDAN EQL PHARMA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 88752
Holder Company Name: Eql Pharma Ab
Marketing Company Name: Eql Pharma Ab
Authorization Date: 2023-03-31
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 2,5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Eql Pharma Ab

LEVOSIMENDAN

2,5 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 31, 2023

Approval ID

e664c51a80e0b887

Type

Standard